University of Colorado, Denver
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Colorado, Denver sits in the top decile of US sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count).
University of Colorado, Denver: 1,283 sponsored US clinical trials, 265 recruiting.
University of Colorado, Denver sponsors 1,283 registered US clinical trials on ClinicalTrials.gov, 265 of them currently recruiting, and 830 completed. 121 of these trials are in Phase 3-4 (later-stage) and 245 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 23 trials.
Top-decile sponsor footprint
University of Colorado, Denver ranks in the top decile of sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
830 of 908 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,283 total, page 13 of 26
Pediatric Oncology Recovery Trial After Surgery
NCT04344899
Prevention of Enamel Demineralization Using CPP-ACP-NaF Varnish
NCT04002232
Suprathel Versus Xeroform for the Management of Skin Graft Donor Sites
NCT04014400
Evaluation of Coffee Therapy for Improvement of Renal Oxygenation
NCT03878277
Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic Cardiovascular Medications
NCT03973931
The Role of Hyperoxia in Acute Ischemic Stroke
NCT03904017
An Implementation Model for Clinical Decision Support for Heart Failure Prescribing
NCT04028557
UControlPain App (This is the Official IRB Title)
NCT03833648
NCARE, Transition to Recovery
NCT03737864
CRI in POTS in Adolescents
NCT03974737
Improving Physical Activity Maintenance of Cancer Survivors
NCT03976193
Histologic Comparison of Healing After Tooth Extraction With Ridge Preservation Using Two Different Xenografts
NCT03769376
Testing a Shortened Version of the AlAn's Game
NCT03834467
Family Learning on Asthma Topics
NCT03894982
Treating PCOS With Semaglutide vs Active Lifestyle Intervention
NCT03919929
Cefadroxil and Cephalexin Drug Levels and Dosing in Pediatric Musculoskeletal Infections
NCT03802552
Effects of Aging and Gender-Affirming Hormone Therapy on Vascular Endothelial Function and Metabolic Profiles in Transgender Women
NCT04066283
Bedside Resources to Gauge Intravascular Volume Status
NCT03915587
A Sports Injury Prevention Program to Reduce Subsequent Injuries After Concussion
NCT03917290
Parent-Reported Symptom Assessments in Children Taking Multiple Medications
NCT03849066
Pregnancy Intervention With a Closed-Loop System (PICLS) Study
NCT03774186
Improving Insulin Resistance and Energy Metabolism Through Sleep Extension in Adolescents
NCT03814512
Underutilization of Hospice in Older African Americans
NCT04458090
Immunoparalysis in Acute Kidney Injury After Cardiac Surgery
NCT03922958
Motivation for Exercise and Physical Activity Adherence
NCT04937205
Characterizing Stray Energy Injuries During Robotic Surgery
NCT03477201
ENgaging in Advance Care Planning Talks Group Visit Intervention for Cognitive Impairment
NCT03711396
Use of Acthar in Patients With FSGS That Will be Undergoing Renal Transplantation
NCT02683889
Evaluation of Speech-in-noise Performance in Cochlear Implant Recipients With a CROS Device on the Contralateral Ear
NCT03867396
Testosterone Therapy in Castration Resistant Prostate Cancer
NCT03734653
Sleep Disruption Induced Impairments in Bone Formation
NCT03733483
Time Restricted Feeding and Metabolic Rhythms
NCT04009239
Comparative Effectiveness of Diabetes Shared Medical Appointment Models
NCT03590041
The RAPID Trial: Assessing Point-of-care Influenza and Other Respiratory Virus Diagnostics
NCT03756753
Mitochondria in HIV and Aging (MITO+)
NCT03489421
Bicarbonate Administration in Kidney Transplant Recipients
NCT03428464
Cannabis Use in Cancer Patients
NCT03617692
Acceptance and Commitment Therapy for Chronic Pain in Cancer Survivors
NCT03661840
Hepatic Mitochondrial Function in Youth
NCT03587727
Radiotherapy With Durvalumab Prior to Surgical Resection for HPV Negative Squamous Cell Carcinoma
NCT03635164
Shared Decision-Making Tool for Opioid Prescribing After Ambulatory Hand Surgery in Veterans
NCT04625231
Nivolumab With Standard of Care Chemotherapy for Peripheral T Cell Lymphomas
NCT03586999
The Influence of in Utero Cannabis Exposure on Neonatal Brain Morphology and Structural Connectivity
NCT03718520
Short Versus Long Interval to Ileostomy Reversal After Ileal Pouch Surgery
NCT03587519
Nutritional Formulation for Angelman Syndrome
NCT03644693
The Effect of Tablet Size on Cognitive Performance Caffeine
NCT03694886
The GAIN Study: Understanding What Helps Children Learn to Like and Eat New Foods
NCT04544332
Resistance Training and Appetite Regulation
NCT03985787
Home-based Delivery of the Contraceptive Implant in Postpartum Guatemalan Women
NCT04005391
Hostile Interpretation Bias Training to Treat Irritability
NCT03592368
What is open in the University of Colorado, Denver pipeline
265 recruiting of 1,283 indexed (21% open); 830 completed (65%).
Phase mix: 121 late (III/IV) vs 245 early (I/II) (early-phase heavy).
Top condition: Obesity (23 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Colorado, Denver: open-pipeline peers nationwide
Peers matched on 1,283 registered trials and 21% open enrollment, not the therapeutic-area sidebar.
University of Colorado, Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,283 trials (± recruiting share)
- AstraZeneca · 1,285 trials · 12% recruiting
- University of Michigan · 1,327 trials · 13% recruiting
- University of Pittsburgh · 1,238 trials · 13% recruiting
- Eli Lilly and Company · 1,341 trials · 9% recruiting
Sponsors near 21% open enrollment (± trial volume)
- Cedars-Sinai Medical Center · 21% recruiting · 339 trials
- Craig Hospital · 21% recruiting · 29 trials
- W.L.Gore & Associates · 21% recruiting · 53 trials
- Georgia Institute of Technology · 21% recruiting · 24 trials
Related
What to do with this University of Colorado, Denver page
1,283 registered trials is a research-attention snapshot, not an endorsement of University of Colorado, Denver or any single study.
- 265 of University of Colorado, Denver's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Colorado, Denver studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Colorado, Denver pipeline card: 1,283 registered trials from official public datasets.Report a data error.